Enwei Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Enwei Pharmaceutical has a total shareholder equity of CN¥1.0B and total debt of CN¥200.0M, which brings its debt-to-equity ratio to 19.6%. Its total assets and total liabilities are CN¥1.4B and CN¥400.9M respectively. Enwei Pharmaceutical's EBIT is CN¥27.8M making its interest coverage ratio -4.9. It has cash and short-term investments of CN¥495.7M.
Key information
19.6%
Debt to equity ratio
CN¥200.00m
Debt
| Interest coverage ratio | -4.9x |
| Cash | CN¥495.66m |
| Equity | CN¥1.02b |
| Total liabilities | CN¥400.93m |
| Total assets | CN¥1.42b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 301331's short term assets (CN¥864.5M) exceed its short term liabilities (CN¥178.0M).
Long Term Liabilities: 301331's short term assets (CN¥864.5M) exceed its long term liabilities (CN¥222.9M).
Debt to Equity History and Analysis
Debt Level: 301331 has more cash than its total debt.
Reducing Debt: 301331's debt to equity ratio has increased from 3.2% to 19.6% over the past 5 years.
Debt Coverage: 301331's debt is well covered by operating cash flow (52.6%).
Interest Coverage: 301331 earns more interest than it pays, so coverage of interest payments is not a concern.